Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2012
Price : $35 *
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure; Left ventricular dysfunction
- Focus Pharmacodynamics
- 24 Aug 2012 New trial record
- 01 Aug 2012 Results published in the Journal of Cardiothoracic and Vascular Anesthesia.